Robert M. MacRae

2.0k total citations · 1 hit paper
56 papers, 1.3k citations indexed

About

Robert M. MacRae is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert M. MacRae has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert M. MacRae's work include Lung Cancer Diagnosis and Treatment (28 papers), Lung Cancer Treatments and Mutations (19 papers) and Advanced Radiotherapy Techniques (13 papers). Robert M. MacRae is often cited by papers focused on Lung Cancer Diagnosis and Treatment (28 papers), Lung Cancer Treatments and Mutations (19 papers) and Advanced Radiotherapy Techniques (13 papers). Robert M. MacRae collaborates with scholars based in Canada, United States and United Kingdom. Robert M. MacRae's co-authors include Hak Choy, Vivek S. Kavadi, Rebecca Paulus, Samir Narayan, Jeffrey D. Bradley, Ritsuko Komaki, Steven E. Schild, Chen Hu, Raymond B. Wynn and Jeffrey A. Bogart and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Robert M. MacRae

48 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

2016 528 citations Stephen G. Chun, Chen Hu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert M. MacRae Canada	14	1.0k	433	432	397	130	56	1.3k
Shervin M. Shirvani United States	17	917 0.9×	436 1.0×	500 1.2×	318 0.8×	154 1.2×	56	1.3k
Cordula Pitz Netherlands	25	1.5k 1.4×	592 1.4×	421 1.0×	653 1.6×	140 1.1×	44	1.8k
Marta Moreno Spain	17	887 0.9×	490 1.1×	477 1.1×	449 1.1×	308 2.4×	58	1.4k
Takuyo Kozuka Japan	17	1.1k 1.1×	484 1.1×	595 1.4×	272 0.7×	291 2.2×	67	1.6k
Rolando Maria D’Angelillo Italy	22	1.1k 1.1×	523 1.2×	406 0.9×	464 1.2×	288 2.2×	112	1.8k
Tine Schytte Denmark	18	655 0.6×	528 1.2×	488 1.1×	242 0.6×	68 0.5×	80	1.0k
Randall Hughes United States	15	889 0.9×	251 0.6×	231 0.5×	631 1.6×	261 2.0×	43	1.4k
Marco Trovò Italy	21	1.3k 1.3×	738 1.7×	665 1.5×	554 1.4×	243 1.9×	88	2.0k
Jana Fox United States	15	644 0.6×	450 1.0×	494 1.1×	246 0.6×	177 1.4×	42	1.1k
Marc-André Mahé France	18	768 0.7×	542 1.3×	350 0.8×	390 1.0×	334 2.6×	89	1.4k

Countries citing papers authored by Robert M. MacRae

Since Specialization

Citations

This map shows the geographic impact of Robert M. MacRae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. MacRae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. MacRae more than expected).

Fields of papers citing papers by Robert M. MacRae

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. MacRae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. MacRae. The network helps show where Robert M. MacRae may publish in the future.

Co-authorship network of co-authors of Robert M. MacRae

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. MacRae. A scholar is included among the top collaborators of Robert M. MacRae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. MacRae. Robert M. MacRae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chun, Stephen G., Chen Hu, Ritsuko Komaki, et al.. (2024). Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer. JAMA Oncology. 10(8). 1111–1111. 10 indexed citations

Alayed, Yasir, et al.. (2024). Effectiveness of palliative hemostatic radiotherapy for hemoptysis: a prospective single-arm observation study. Annals of Palliative Medicine. 13(6). 1343–1352.

Phillips, William J., Fred Saad, Colleen Webber, et al.. (2024). Real-World Evaluation of Primary Versus Secondary Prevention of Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer. The Oncologist. 29(10). 878–886. 1 indexed citations

Weidhaas, Joanne B., Chen Hu, Ritsuko Komaki, et al.. (2023). The Inherited KRAS -variant as a Biomarker of Cetuximab Response in NSCLC. Cancer Research Communications. 3(10). 2074–2081. 1 indexed citations

Cygler, Joanna, et al.. (2023). 4D Monte Carlo dose reconstructions using surface motion measurements. Physica Medica. 114. 103135–103135.

Fung‐Kee‐Fung, Michael, Bill Davies, Stephanie Pick, et al.. (2022). Cancer Clinic Redesign: Opportunities for Resource Optimization. Current Oncology. 29(6). 3983–3995.

Roy, Soumyajit, Scott C. Morgan, Daniel E. Spratt, et al.. (2021). Association of Baseline Patient-reported Health-related Quality of Life Metrics with Outcome in Localised Prostate Cancer. Clinical Oncology. 34(1). e61–e68. 1 indexed citations

Shamji, Farid M., et al.. (2021). Guiding Principles on the Importance of Thoracic Surgical Education on Establishing Integrated Thoracic Surgery Program, Interdisciplinary Thoracic Oncology Conferences, and an Interdisciplinary Approach to Management of Thoracic Malignancies. Thoracic surgery clinics/Thorac. surg. clin.. 31(4). 367–377. 1 indexed citations

Kong, Feng‐Ming, Chen Hu, Weili Wang, et al.. (2020). RTOG0617 to Externally Validate Blood Cell ERCC1/2 Genotypic Signature as a Radiosensitivity Biomarker for Both Tumor and Normal Tissue for Individualized Dose Prescription. International Journal of Radiation Oncology*Biology*Physics. 108(3). S2–S2. 3 indexed citations

10.

MacRae, Robert M., Miranda Ashton, Olivia Lauk, et al.. (2019). The role of radiation treatment in pleural mesothelioma: Highlights of the 14th International Conference of the International mesothelioma interest group. Lung Cancer. 132. 24–27. 7 indexed citations

11.

Rodrigues, George, Slav Yartsev, David Roberge, et al.. (2019). A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain Oligometastases. Cureus. 11(12). e6394–e6394. 5 indexed citations

12.

Laurie, Scott A., Shantanu Banerji, Normand Blais, et al.. (2019). Canadian Consensus: Oligoprogressive, Pseudoprogressive, and Oligometastatic Non-Small-Cell Lung Cancer. Current Oncology. 26(1). 81–93. 35 indexed citations

13.

Seely, Jean M., et al.. (2018). P2.16-19 Feasibility and Outcomes of Radiofrequency Ablation as Salvage Modality After Hypofractionated Radiation/SBRT for Early NSCLC. Journal of Thoracic Oncology. 13(10). S838–S838. 1 indexed citations

14.

Dennie, Carole, et al.. (2017). Quantitative texture analysis on pre-treatment computed tomography predicts local recurrence in stage I non-small cell lung cancer following stereotactic radiation therapy. Quantitative Imaging in Medicine and Surgery. 7(6). 614–622. 11 indexed citations

15.

Holmes, Oliver, et al.. (2017). Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer. Clinical and Translational Radiation Oncology. 5. 37–41. 4 indexed citations

16.

Brade, Anthony, Robert M. MacRae, Scott A. Laurie, et al.. (2015). Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non–Small Cell Lung Cancer. Clinical Lung Cancer. 17(2). 133–141. 8 indexed citations

17.

Bar, Jair, Patrícia Moretto, Glenwood D. Goss, et al.. (2012). Chemoradiotherapy for Locoregional Recurrence of Non–Small-Cell Lung Cancer After Surgical Resection: A Retrospective Analysis. Clinical Lung Cancer. 14(2). 200–204. 24 indexed citations

18.

Brade, Anthony, Andrea Bezjak, Robert M. MacRae, et al.. (2010). Phase I Trial of Radiation With Concurrent and Consolidation Pemetrexed and Cisplatin in Patients With Unresectable Stage IIIA/B Non–Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 79(5). 1395–1401. 28 indexed citations

19.

Agarwal, Prachi, Jean M. Seely, Fred Matzinger, et al.. (2006). Pleural Mesothelioma: Sensitivity and Incidence of Needle Track Seeding after Image-guided Biopsy versus Surgical Biopsy. Radiology. 241(2). 589–594. 82 indexed citations

20.

MacRae, Robert M. & Hak Choy. (2003). Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancer. Current Oncology Reports. 5(4). 313–317. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact